NCT00181233 Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
| NCT ID | NCT00181233 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | Sudden Cardiac Death |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2003-10 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2003-10 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sudden cardiac death is a tragic event that strikes all age groups and is unfortunately increasing in prevalence. Because it is difficult to predict those at highest risk, this study is designed to test the hypothesis that new imaging techniques (magnetic resonance imaging \[MRI\] and computed tomography \[CT\]) are useful for identifying factors which put people at high risk for sudden death.
Eligibility Criteria
Inclusion Criteria: * Left ventricular ejection fraction \<or = 35% * Planned implantable cardioverter-defibrillator (ICD) implantation for clinical indications (primary prevention) Exclusion Criteria: * History of sudden death (secondary prevention) * Contraindication to undergoing MRI (metallic implant, pacemaker, etc.)
Contact & Investigator
Katherine C Wu, MD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT00181233 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sudden Cardiac Death. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00181233 currently recruiting?
Yes, NCT00181233 is actively recruiting participants. Contact the research team at bbutche1@jhmi.edu for enrollment information.
Where is the NCT00181233 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT00181233 clinical trial?
NCT00181233 is sponsored by Johns Hopkins University. The principal investigator is Katherine C Wu, MD at Johns Hopkins University. The trial plans to enroll 400 participants.